secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2022-12-12T23:59:59+00:00
Accession:  0000950170-22-026382
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences receives Nasdaq delisting notice for bid price non-compliance
--------------------------------------------------------------------------------

- Received Nasdaq notice on Dec. 6, 2022, for failing to maintain $1.00 minimum bid price.
- 180-day grace period expired Dec. 5, 2022; a separate basis for delisting has been identified.
- Company will provide a compliance plan to Nasdaq Hearings Panel and has requested a hearing.
- Trading continues on Nasdaq under REVBU, REVB, and REVBW while review is pending.
- No assurance that extension or continued listing will be granted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017022026382/0000950170-22-026382-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017022026382/revb-20221206.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-026382

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer